Lennep, Brandon W.
Mack, Jesse
Poondru, Srinivasu
Hood, Elizabeth
Looney, Brooke D.
Williams, Monique
Bianco, Judeth J.
Morgans, Alicia K.
Funding for this research was provided by:
Pfizer
Astellas Pharma US
Article History
Accepted: 25 February 2024
First Online: 12 April 2024
Declarations
:
: Funding was provided by Pfizer Inc. and Astellas Pharma, Inc.
: Brandon Lennep has received consulting fees from Pfizer Inc. Jesse Mack is an employee of Astellas Pharma Inc. and was a consultant for Pfizer prior to joining Astellas Pharma Inc. Srinivasu Poondru is an employee of Astellas Pharma Inc. Brooke Looney receives research support from AstraZeneca Inc. and Pfizer Inc. and has served as a speaker for AstraZeneca Inc. Judeth Bianco is an employee of Pfizer Inc. Alicia Morgans has received consulting fees from Astellas Pharma Inc., AAA Pharma Inc., AstraZeneca Pharma LP, Bayer HealthCare Pharma LLC, Dendreon Pharma LLC, Janssen Pharma LLC, Exelixis Inc., Myovant Sciences, Inc., Merck & Co. Inc., Novartis AG, Lantheus, Telix Pharma Limited, Sanofi S.A., and Pfizer Inc., research fees from Bayer HealthCare Pharma LLC, Myovant Sciences Inc., and Pfizer Inc., and travel support from Telix Pharma Limited and Sanofi S.A. Elizabeth Hood and Monique Williams have no financial interests to declare.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: BL, AM, and JB contributed to the conception of the study. All authors contributed to the design and interpretation of the results. All authors contributed to the drafting of the paper and/or to its revision or critical review. All authors gave final approval of the version to be published and agree to be accountable for all aspects of the work.